MedPath

ROCURONIUM BROMIDE

ROCURONIUM BROMIDE INJ. 100mg/10mL (10mg/mL) 10mL VIAL

Approved
Approval ID

818f7cc6-2c3f-1788-e053-2991aa0a4c6a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 1, 2021

Manufacturers
FDA

HF Acquisition Co LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ROCURONIUM BROMIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51662-1355
Application NumberANDA078519
Product Classification
M
Marketing Category
C73584
G
Generic Name
ROCURONIUM BROMIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMarch 1, 2021
FDA Product Classification

INGREDIENTS (5)

SODIUM CHLORIDEInactive
Quantity: 3.1 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
ROCURONIUM BROMIDEActive
Quantity: 10 mg in 1 mL
Code: I65MW4OFHZ
Classification: ACTIB
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SODIUM ACETATEInactive
Quantity: 2 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ROCURONIUM BROMIDE - FDA Drug Approval Details